989-56 Serial Changes of Plasma Vitronectin Level in Patients with Acute Myocardial Infarction: Possible Role of VN as a Scavenger of Plasminogen Activator Inhibitor-1  by Sakamoto, Tomohiro et al.
JACC February 1995 ABSTRACfS 311A
1989-571Dru~ infusion started with an initial bolus (PD145065 3 mglkg; n ~ 10 or ETl
10- 0m/kg; n ~ 9) 10 min before occlusion followed by 10-11 m/kg/min of
ET1 or 0.6 mglkg/min of PD145065 for 2 hrs and 40 minutes. Control an-
imals (n ~ 10) received the same volumes in saline. Infarct size (AN) was
measured histologically and expressed as percentage of area at risk (AR).
Results as Mean ± SEM.
Increased Plasma Soluble Intercellular Adhesion
Molecule-1 (sICAM-1) Levels in Coronary
Circulation in Patients with Unstable Angina
Hisao Ogawa, Tomohiro Sakamoto, Yuji Miyao. Koich; Kaikita, Hisakazu Suefuji,
Hirofumi Yasu8. Kumamoto University. Kumamoto, Japan
To determine whether plasma sICAM-1 levels increase in the coronary circu-
lation in patients (pts) with unstable angina, we measured plasma sICAM-1
levels in the coronary sinus (CS) and aortic root (Ao) simultaneously in 18 un-
stable angina pts (UA), 18 stable exertional angina pts (SEA) and 14 control
pts (Cont). Unstable angina was defined as worsening effort or rest angina.
or both within 1 month of catherization. The three groups were matched for
age and gender. The levels of sICAM-1 were measured by enzyme-linked
immunosorbent assay. Data are shown below as means ± SE Ing/ml).
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The mean values of CS and Ao were significantly higher in UA than in SEA
and in Cont. Furthermore. in UA the mean value was higher in CS than in
Ao. There were no significant differences of the mean values of CS and Ao
between SEA and Cont. We conclude that sICAM-1 release is increased es-
pecially in coronary circulation in UA. ICAM-1 is known to be a major ligand
on endothelial cells for adherence of activated leukocyles. These results sug-
gest that activation of leukocytes take place within coronary circulation, fur-
ther may activate platelet and induce coronary thrombosis in UA.
'p < 0.01 vs SEA and Cont, # p < 0.01 vs Ao
The presence of intercellular adhesion molecule-1 (ICAM-1) on arterial en-
dothelial cells and on non-endothelial cells has previously demonstrated in
human coronary atherosclerotic plaques. We hypothesized that ICAM-1 ex-
pression on coronary arteries is increased by mechanical compression of
coronary atherosclerotic plaques such as coronary balloon angioplasty. Coro-
nary thrombolysis (intravenous administration of alteplase. 0.45 mg/kg) was
done in 31 consecutive patients with acute myocardial infarction (AMI) imme-
diately after admission. Thirteen patients whose coronary arteries were not
recanalized completely (below TIMI grade 2) were performed subsequent
coronary angioplasty. Blood sampling were done on admission, 2. 4. 8. 12,
24,48, 72 and 96 hours after admission.
Plasma levels of soluble ICAM-1 were measured by enzyme-linked im-
munosorbent assay. Plasma soluble ICAM-1 level was increased significantly
in patients with angioplasty (p ~ 0.03. vs patients without angioplasty) and
the level reached a peak 8 hours after admission (116 ± 7% of baseline level).
On the other hand. the level was unchanged in patients without angioplasty
(99 ± 3% of baseline. 8 hours after admission).
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Conclusion: Plasma levels of soluble ICAM-1 are increased after angio-
plasty in patients with AMI. Mechanical stimulation of coronary atheroscle-
rotic plaques by balloon catheter may induce activation of mononuclear
leukocyte or T-lymphocyte in the vessel wall. Cytokines released from the
activated leukocyte may amplify the synthesis of ICAM-1 on the endothe-
lium and increase the plasma level of ICAM-1 .
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Serial Changes of Plasma Vitronectin Level in
Patients with Acute Myocardial Infarction:
Possible Role of VN as a Scavenger of
Plasminogen Activator Inhibitor·1
Tomohiro Sakamoto. Hisao Ogawa, Hisakazu Suefuji, Koichi Kaikita. NTTKyushu
Hospital and Kumamoto University, Kumamoto. Japan
Conclusions: 1. Myocardial rep after ischemia is associated with marked
reactive hyperemia. This flow decreases significantly in the CIZ at 3 hrs into
rep demonstrating for the first time that the "no-reflow phenomenon" exists
in the rabbit model. 2. ET1 mRNA was elevated in the CIZ at 3 hrs, suggest-
ing a cause-effect relationship between ET1 production and the "no-reflow
phenomenon". 3. Exogenous infusion of ET1 fails to alter infarct size but an-
tagonism of the ETAlB receptors significantly reduces infarct size in rabbits
and this might represent a novel therapy for acute myocardial infarction in
man.
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Vitronectin (VN) is an adhesive glycoprotein that promotes cell adhesion and
spreading and located in mainly extracellular matrix. VN is also known to
regulate the fibrinolytic system by forming complexes with plasminogen ac-
tivator inhibitor (PAI)-1. To elucidate the serial changes of plasma VN level
in association with fibrinolytic capacity in patients with acute myocardial in-
farction (AMI), we measured plasma levels of VN as well as PAl activity. PAI-5
antigen and tissue plasminogen activator (t-PA)-PAI-1 complexes antigen in
20 consecutive AMI patients. All patients were administered alteplase 0.45
mg/kg intravenously for coronary thrombolysis. Blood sampling was done
on admission. 4. 8. 12. 16. 20. 24 and 48 hours; 3. 4. 5. 6 and 7 days after
admission. PAl activity. PAI-1 antigen and t-PA-PAI-1 complexes antigen lev-
els were increased 4 hours after admission (p < 0.01 vs admission) and the
levels maintained higher level during the first 24 hours. On the other hand,
VN levels were increased at 48 hours (p < 0.01 vs admission) and showed
a tendency to be high until 7 days. In contrast to the VN level. PAl activity.
PAI-1 antigen and t-PA-PAI-1 complexes antigen levels were decreased after
48 hours (p < 0.05 vs 4 hours). We conclude that VN is increased 48 hours
after admission with complementary decreasing of PAI-1 in AMI patients. It
is possible that VN removes PAI-1 from the circulation to the extracellular
matrix where VN exists by forming the complexes. These results suggest
that VN may act as a scavenger of PAI-l and playa protective role for the
fibrinolytic system in patients with AM I.
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